A retrospective observational study on effectiveness of influenza vaccine Supemtek® compared to other vaccines in adults aged 18 years and above in the United Kingdom – a feasibility study

16/12/2022
23/04/2024
EU PAS number:
EUPAS50220
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information